The science
The clinical question underneath this product is a diagnostic one, and it is the reason a formula this mismatched to its own name still satisfies thousands of buyers. Xerosis of the scalp — true dryness — and seborrhoeic dermatitis present with overlapping symptoms but arise from opposite mechanisms. Dryness reflects insufficient stratum corneum hydration and impaired barrier lipids, producing fine white scale. Seborrhoeic dermatitis reflects an inflammatory response to Malassezia, lipophilic commensal yeasts that hydrolyse sebum triglycerides into free fatty acids, principally oleic acid, which provoke irritation and accelerate epidermal proliferation in susceptible individuals. The scale it produces is larger, often greasy, and typically accompanied by erythema. Because both feel tight and itchy, patient self-report is unreliable — and moisturisation, the intuitive response, addresses only one of them.
Selenium sulfide's activity against the second is well documented, and its mechanism is unusually broad for an over-the-counter agent. It is antifungal against Malassezia species and additionally cytostatic, directly reducing the rate of epidermal cell production. That dual action is why it sits alongside ketoconazole in potency and above pyrithione zinc, and why the monograph permits labelling for seborrheic dermatitis rather than dandruff alone. The federal framing matters too: as a monograph drug, both the identity and the one percent strength are externally defined rather than chosen by the manufacturer.
What the formulation does not support is the dryness half of its positioning. There is no humectant, no emollient and no barrier lipid in the inactive list, and the vehicle is led by sodium lauryl sulfate — a surfactant repeatedly shown in irritancy testing to increase transepidermal water loss and disrupt barrier function relative to milder alternatives. Dimethicone, the sole conditioning agent, is a hair-shaft treatment rather than a skin one. On a scalp with genuine barrier impairment, this vehicle works against the goal the name states.
The mint components warrant their own note. Menthol produces cooling by agonism at the TRPM8 cold receptor, a sensory effect with no anti-inflammatory action; the perceived relief is counter-irritation rather than treatment. Menthol and peppermint oil both appear in contact dermatitis literature as sensitisers, and applying them to compromised skin is the circumstance under which reactions are most likely. The defensible reading is that the drug in this bottle is excellent for the condition most buyers actually have, and the cosmetic decisions around it were made for the condition they think they have.